Results 81 to 90 of about 263 (155)

Longer-Term Efficacy and Safety of Evinacumab in Patients With Refractory Hypercholesterolemia.

JAMA Cardiol, 2023
Rosenson RS, Burgess LJ, Ebenbichler CF, Baum SJ, Stroes ESG, Ali S, Khilla N, McGinniss J, Gaudet D, Pordy R.   +9 more
europepmc   +1 more source

Effectiveness of surgical treatments on healing of cartilage and function level in patients with osteochondral lesions of the tibial plafond: A systematic review. [PDF]

J Orthop, 2021
Jagtenberg EM, Kalmet PHS, de Krom MAP, Hermus JPS, Seelen HAM, Poeze M.   +5 more
europepmc   +1 more source

Reversion from chronic migraine to episodic migraine following treatment with erenumab: Results of a post-hoc analysis of a randomized, 12-week, double-blind study and a 52-week, open-label extension. [PDF]

Cephalalgia, 2021
Lipton RB, Tepper SJ, Silberstein SD, Kudrow D, Ashina M, Reuter U, Dodick DW, Zhang F, Rippon GA, Cheng S, Mikol DD.   +10 more
europepmc   +1 more source

Long-term efficacy and safety of erenumab in migraine prevention: Results from a 5-year, open-label treatment phase of a randomized clinical trial. [PDF]

Eur J Neurol, 2021
Ashina M, Goadsby PJ, Reuter U, Silberstein S, Dodick DW, Xue F, Zhang F, Paiva da Silva Lima G, Cheng S, Mikol DD.   +9 more
europepmc   +1 more source

Kajian Pendekatan Binary Log dalam Change Data Capture

Jurnal Ilmiah Merpati (Menara Penelitian Akademika Teknologi Informasi), 2017
The online business era causes the form of transactions to occur so quickly that the information stored in the data warehouse becomes invalid. Companies are required to have a strong system, which is a system that is real time in order to be able to ...
Muhammad Febrian Rachmadhan Amri, I Made Sukarsa, I Ketut Adi Purnawan   +2 more
doaj  

Nucleus accumbens D1/D2 circuits control opioid withdrawal symptoms in mice. [PDF]

J Clin Invest, 2023
Zhu Y, Wang K, Ma T, Ji Y, Lou Y, Fu X, Lu Y, Liu Y, Dang W, Zhang Q, Yin F, Wang K, Yu B, Zhang H, Lai J, Wang Y.   +15 more
europepmc   +1 more source

Efficacy of Erenumab for Migraine Prevention in Japanese Patients with Episodic and Chronic Migraine: Results of a Post-Hoc Pooled Analysis. [PDF]

Neurol Ther, 2023
Kitamura S, Takeshima T, Yui D, da Silva Lima GP, Koukakis R, Peng C, Yoshida R, Numachi Y, Hasebe M.   +8 more
europepmc   +1 more source

Reduction in acute migraine-specific and non-specific medication use in patients treated with erenumab: post-hoc analyses of episodic and chronic migraine clinical trials. [PDF]

J Headache Pain, 2021
Tepper SJ, Ashina M, Reuter U, Hallström Y, Broessner G, Bonner JH, Picard H, Cheng S, Chou DE, Zhang F, Klatt J, Mikol DD.   +11 more
europepmc   +1 more source

Educational innovation: the architecture of digital technologies as a catalyst for change in university teacher training. [PDF]

Sci Rep, 2023
Flores-Chacón E, Pacheco A, Gonzales-Ortiz Y, Moreno-Vega L, Del-Castillo-Palacios F, Perez-Rojas E.   +5 more
europepmc   +1 more source

Monoclonal Antibodies Targeting CGRP: From Clinical Studies to Real-World Evidence-What Do We Know So Far? [PDF]

Pharmaceuticals (Basel), 2021
Mavridis T, Deligianni CI, Karagiorgis G, Daponte A, Breza M, Mitsikostas DD.   +5 more
europepmc   +1 more source